Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Test for Homogeneity

Test for Homogeneity

The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...

Variability: Analysis

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...

Comparing the Survival Analysis of Two or More Groups

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Multiple Comparison Tests

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Co-medications and gut microbiome in NSCLC immunotherapy.

The Lancet. Oncology·2026

Same author

Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in <i>KRAS</i>-mutant non-small cell lung cancer.

Science advances·2026

Same author

Understanding immune checkpoint inhibitor efficacy through spatial decoding of the lung cancer tumor immune microenvironment.

The Journal of clinical investigation·2026

Same author

Association of Vaping-Related Events with Relative Harm Perceptions of E-Cigarettes.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2026

Same author

Cancer cachexia in STK11/LKB1-mutated non-small cell lung cancer is dependent on tumor-secreted GDF15.

Nature communications·2026

Same author

ISL1: A Novel Neuroendocrine Subtype in Small Cell Lung Cancer Predicts Durable Response to Lurbinectedin.

Molecular cancer therapeutics·2026

Search research articles

Related Experiment Video

Updated: Apr 20, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

On comparing heterogeneity across biomarkers.

Robert J Steininger¹, Satwik Rajaram², Luc Girard³

¹Green Center for Systems Biology, University of Texas Southwestern Medical Center, Dallas, Texas.

Cytometry. Part a : the Journal of the International Society for Analytical Cytology

|November 27, 2014

Summary

Many microscopy biomarkers provide redundant information about cellular heterogeneity. This study introduces a new framework to identify independently informative biomarkers, aiding biological network and state space analysis.

Keywords:

bioimage informatics biological networks biomarker selection; systems biology heterogeneity information theory microscopy single-cell variability

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Related Experiment Videos

Last Updated: Apr 20, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

Area of Science:

Cell Biology
Biophysics
Computational Biology

Background:

Microscopy reveals cellular heterogeneity, but simultaneous biomarker monitoring is limited.
Understanding cellular states requires assessing information gained from multiple biomarkers.

Purpose of the Study:

Develop a framework to compare phenotypic states across biomarkers without costaining.
Evaluate the redundancy of information provided by different biomarkers.
Guide the selection of independently informative biomarkers.

Main Methods:

A novel framework for comparing phenotypic states across biomarkers using diverse cell lines.
Validation against the gold standard of costaining.
Application to lung cancer cell line datasets with varying numbers of biomarkers.

Main Results:

The developed framework effectively compares phenotypic states across biomarkers.
Many tested biomarkers provide redundant information regarding cellular heterogeneity.
Identified specific biomarkers yielding similar heterogeneity patterns.

Conclusions:

A significant portion of microscopy biomarkers offer redundant information on cellular heterogeneity.
The framework provides a practical method for selecting informative biomarkers.
Insights into biological network connectivity and biological system state space complexity are gained.